Sorrento Therapeutics
San Diego, California, United StatesFounded 2006
Sorrento Therapeutics is a biopharmaceutical company focused on developing next-generation treatments for cancer, infectious diseases, and pain. It is not a venture capital firm.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is growth (100% of deals).
Portfolio
1
Fund Size
—
Top Stage
Growth
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
| CCelularity | Growth | $250M | Feb 2018 |
Top Co-Investors
Celgene1 shared
Last updated: 28 April 2026